Home MetaBloQ

MetaBloQ

In operation
-
Cancer Drug Developer

Basic Information

MetaBloQ is a private biotechnology company developing drugs for cancer treatment, primarily focusing on triple-negative breast cancer. Together with its partners, the company is conducting a drug discovery and development project targeting a novel target involved in cancer metabolism.
Metabloq Pty Ltd
Melbourne,Victoria,Australia
less than 15 people
January 01, 2015
--
info@metabloqpharma.com